Svetlana Lucas insider trades: Scribe Therapeutics (SCTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Svetlana reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | SCTX | ↑ Buy | 3,000 | $15.00 | $45K | By Spouse | Jul 27, 2026 (4d) |
| Sep 22, 2025 | JSPR | ↑ Buy | 20,000 | $2.43 | $49K | Direct | Sep 24, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SCTX insiders
Open-market trades in the last 12 months
About Svetlana Lucas's insider trades
Svetlana Lucas is Chief Business Officer at Scribe Therapeutics (SCTX). Since Sep 22, 2025, Svetlana has reported 2 open-market purchases worth $94K and no sales on SEC Form 4. In the last 12 months: 1 buy ($45K).
Their filings also include grants and awards (12 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.